Top 5 FDA Drug Approvals of 2017


The most read FDA approval articles on The American Journal of Pharmacy Benefits.

In 2017, the FDA issued approval to dozens of new drugs and existing treatments granted new indications. Here’s a glance at the most popular approvals on The American Journal of Pharmacy Benefits in the past year.

5. FDA Approves EpiPen Competitor

Epinephrine injection pre-filled syringe may help lower costs. Read more.

4. FDA Approves 2 New Asthma Inhalers

Both RespiClick inhalers were observed to improve lung function in patients with asthma. Read more.

3. FDA Approves New Treatment for Complicated Urinary Tract Infections

Antibacterial regimen of meropenem-vaborbactam showed superior efficacy and comparable tolerability compared with piperacillin/tazobactam (Zosyn). Read more.

2. Osteoarthritis Knee Pain Drug Gets FDA Approval

Zilretta is the first non-opioid, extended-release, intra-articular injection for the treatment of osteoarthritis knee pain. Read more.

1. FDA Approves New Fluoroquinolone Antibiotic

Delafloxacin (Baxdela) indicated to treat acute bacterial skin and skin structure infections. Read more.

Related Videos
A panel of 4 experts on breast cancer
A panel of 4 experts on breast cancer
Pride flags during pride event -- Image credit: ink drop |
Video 14 - "Closing Remarks on RSV Vaccinations"
Video 13 - "Understanding RSV Infection Patterns and Seasonal Outbreaks"
A panel of 4 experts on breast cancer
A panel of 4 experts on breast cancer
Female Pharmacist Holding Tablet PC - Image credit: Tyler Olson |
pain management palliative care/Image Credits: © Aleksej -
© 2024 MJH Life Sciences

All rights reserved.